Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management
Background: Chronic pain is a complex condition affecting patients’ health-related quality of life (HRQoL). Pharmacogenetic (PGx) testing offers an approach to personalize pain management by optimizing medication regimens. However, the impact of this approach on measurable patient reported outcomes...
Saved in:
| Main Authors: | Anna Bollinger, Kurt E. Hersberger, Julia Gianora, Isabelle O. Urdieux, Henriette E. Meyer zu Schwabedissen, Nikki Rommers, Matthias Schwenkglenks, Céline K. Stäuble, Samuel S. Allemann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Health Services Insights |
| Online Access: | https://doi.org/10.1177/11786329251356560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
by: Anna Bollinger, et al.
Published: (2025-01-01) -
Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol
by: Florine M. Wiss, et al.
Published: (2024-12-01) -
St. John’s Wort Extract Increases Pgp Expression in the Brain but Not in the Small Intestine or the Liver of Wistar Rats
by: Valerio Taggi, et al.
Published: (2025-06-01) -
The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data
by: Wittwer NL, et al.
Published: (2025-08-01) -
Benefits of medication charts provided at transitions of care: a narrative systematic review
by: Fine Michèle Dietrich, et al.
Published: (2020-10-01)